Metraipolis › archive › dc_63c7a982e136
Polatuzumab Vedotin Induced CD20 Upregulation Contributes to the Efficacy of Mosunetuzumab in Combination With Polatuzumab Vedotin in Diffuse Large B-Cell… — Europe PMC PMID:41140808
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41140808
- DOI
- 10.1002/jha2.70169
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T01:57:44.689Z
- SHA-256 of the archived text
266c6bf4f1334d44e9fd46b563eb36f87365e6b55ddeff50d208a2ae256f9ac8- Stable URL of this page
https://metraipolis.com/documento/dc_63c7a982e136
How to cite
Polatuzumab Vedotin Induced CD20 Upregulation Contributes to the Efficacy of Mosunetuzumab in Combination With Polatuzumab Vedotin in Diffuse Large B-Cell… — Europe PMC PMID:41140808 — Europe PMC (en), https://europepmc.org/article/MED/41140808 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_63c7a982e136 (Metraipolis archive dc_63c7a982e136, sha256 266c6bf4f1334d44e9fd46b563eb36f87365e6b55ddeff50d208a2ae256f9ac8)
BibTeX
@misc{dc63c7a982e136,
title = {Polatuzumab Vedotin Induced CD20 Upregulation Contributes to the Efficacy of Mosunetuzumab in Combination With Polatuzumab Vedotin in Diffuse Large B-Cell… — Europe PMC PMID:41140808},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41140808},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_63c7a982e136; sha256 266c6bf4f1334d44e9fd46b563eb36f87365e6b55ddeff50d208a2ae256f9ac8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41140808. Agents can read the archived copy with the MCP tool read_document.